News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,410 Results
Type
Article (44214)
Company Profile (361)
Press Release (690835)
Section
Business (219549)
Career Advice (2278)
Deals (37897)
Drug Delivery (103)
Drug Development (85180)
Employer Resources (174)
FDA (16864)
Job Trends (15872)
News (369813)
Policy (35147)
Tag
Academia (2637)
Alliances (53013)
Alzheimer's disease (1269)
Approvals (16785)
Artificial intelligence (148)
Bankruptcy (376)
Best Places to Work (11919)
Biotechnology (228)
Breast cancer (133)
Cancer (1163)
Cardiovascular disease (109)
Career advice (1906)
Cell therapy (252)
Clinical research (67718)
Collaboration (414)
Compensation (207)
COVID-19 (2639)
C-suite (102)
Data (1168)
Diabetes (164)
Diagnostics (6393)
Drug pricing (96)
Earnings (91261)
Employer resources (153)
Events (118781)
Executive appointments (330)
FDA (17428)
Funding (373)
Gene therapy (192)
GLP-1 (653)
Government (4533)
Healthcare (19321)
Infectious disease (2730)
Inflammatory bowel disease (112)
Interviews (356)
IPO (17047)
Job creations (4339)
Job search strategy (1640)
Layoffs (454)
Legal (8805)
Lung cancer (180)
Manufacturing (194)
Medical device (13617)
Medtech (13622)
Mergers & acquisitions (20922)
Metabolic disorders (459)
Neuroscience (1566)
NextGen Class of 2024 (6843)
Non-profit (4602)
Northern California (1519)
Obesity (266)
Opinion (224)
Patents (112)
People (60338)
Pharmaceutical (105)
Phase I (21005)
Phase II (29727)
Phase III (22314)
Pipeline (469)
Postmarket research (2758)
Preclinical (8919)
Radiopharmaceuticals (250)
Rare diseases (239)
Real estate (6548)
Regulatory (23170)
Research institute (2402)
Resumes & cover letters (382)
Southern California (1333)
Startups (3864)
United States (14178)
Vaccines (585)
Weight loss (211)
Date
Today (213)
Last 7 days (679)
Last 30 days (3757)
Last 365 days (37232)
2024 (34289)
2023 (41398)
2022 (52629)
2021 (57307)
2020 (55715)
2019 (48476)
2018 (36700)
2017 (34087)
2016 (33980)
2015 (39999)
2014 (34447)
2013 (29548)
2012 (31655)
2011 (32323)
2010 (30669)
Location
Africa (838)
Arizona (211)
Asia (41860)
Australia (6652)
California (3441)
Canada (1321)
China (262)
Colorado (155)
Connecticut (165)
Europe (90068)
Florida (475)
Georgia (122)
Illinois (370)
Indiana (211)
Maryland (597)
Massachusetts (2754)
Michigan (174)
Minnesota (289)
New Jersey (1008)
New York (987)
North Carolina (784)
Northern California (1519)
Ohio (142)
Pennsylvania (862)
South America (1228)
Southern California (1333)
Texas (500)
Washington State (382)
735,410 Results for "cardiome pharma corp formerly nortran pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
StimCell Energetics Inc. (Formerly “Cell MedX Corp.”) Announces Major Corporate Updates and Rebranding
November 4, 2024
·
3 min read
Protect Pharmaceutical Corp. Issues Corporate Update
Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: “July 1, 2024 Dear Shareholders: The Company’s PCAOB audit for the fiscal year of 2023 is near completion.
July 1, 2024
·
4 min read
News
SPI Pharma, Inc. and Inimmune, Corp. Partner to Develop and Commercialize Innovative Vaccine Adjuvant Systems
July 16, 2024
·
2 min read
Press Releases
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and Denali
November 7, 2024
·
13 min read
Press Releases
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.
November 14, 2024
·
3 min read
Press Releases
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger
November 11, 2024
·
10 min read
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
Deals
Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.
Visiox Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, and PowerUp Acquisition Corp. announced the execution of a definitive agreement for a business combination that would result in Visiox becoming a publicly traded company on the Nasdaq Capital Market.
December 27, 2023
·
12 min read
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Biotech Beach
ZMI Management Inc. Finalizes Acquisition of ZIMHI™ from DMK Pharmaceuticals Corporation; Partners with FFF Enterprises as Sole Distributor
ZMI Pharma, Inc. announced that it has finalized the acquisition of all strategic assets necessary to manufacture ZIMHI™, including all patents, inventory, automated assembly systems, and the services of two members of the legacy management team.
June 20, 2024
·
3 min read
1 of 73,541
Next
